Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
The authors assessed the use of 1 g tranexamic acid (TA) versus placebo in elective cesarean section in 223 women. The endpoint was the perioperative fall in hemoglobin, which was less in those receiving TA: Hb difference 1.11 ± 0.62 g/dL in those who received TA versus 1.27 ± 0.66 g/dL in the controls (p = 0.034). No adverse effects were seen. However, the study design was imperfect.
– Beverley J. Hunt
NATA: Network for the advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and ther heathcare professionals.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.